Company intelligence / Profile preview

Centre for Human Drug Research

Leiden, Netherlandschdr.nl ↗

Ownership: Private
Employees: ~384
Development stage: Other

Overview

CHDR conducts innovative early-stage clinical trials to demonstrate proof-of-pharmacology and collect high-quality pharmacodynamic data. It has developed proprietary tools like NeuroCart for CNS studies and offers both inpatient and decentralized trial capabilities. The institute has over three decades of experience supporting biopharma clients with end-to-end early phase solutions but does not develop its own drugs or maintain an internal pipeline.

Therapeutic areas: NeurologyPsychiatryDermatologyOncologyImmunology
Modalities: Small moleculeBiologicMonoclonal antibodyPeptides
Industry: Contract Research Organization

Beyond the preview

Go deeper on Centre for Human Drug Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centre for Human Drug Research.

Explore the full profile